Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
The drugmaker Gilead Sciences on Wednesday announced a plan to allow six generic pharmaceutical companies in Asia and North ...
GILD Grants Right for HIV PrEP Candidate to Six Generic Companies
Gilead signs non-exclusive, royalty-free voluntary licensing agreements with six generic companies to market its ...
Outlook Business16h
Hetero Inks Voluntary Licensing Pact with Gilead for HIV Drug Lenacapavir
Hetero has partnered with Gilead Sciences to manufacture and distribute the HIV drug lenacapavir in 120 low- and ...
BioSpace6h
Gilead Partners With Generics Developers to Provide HIV Drug to Low-Income Countries
Gilead Sciences is granting licenses to six companies to produce lenacapavir for pre-exposure prophylaxis, as well as for ...
Quick access to key HIV drug hinges on waiver of local clinical trials: Experts
Faster access to HIV drug lenacapavir in India hinges on the waiver of local clinical trials. Six companies, including three ...
Indian pharma firms ink deal with U.S. drug maker Gilead to make, market generic HIV drug lenacapavir
Dr. Reddy's, Hetero, and Mylan partner with Gilead Sciences to manufacture generic lenacapavir for HIV prevention globally.
Gilead signs agreements to facilitate access to HIV prevention drug
Gilead Sciences has announced the signing of voluntary licencing agreements with six generic pharmaceutical manufacturers to ...
India Today7h
Indian pharma firms sign deal to produce, sell generic HIV drug lenacapavir
Indian pharmaceutical companies are set to produce generic versions of lenacapavir, an HIV prevention drug, under agreements ...
India Infoline15h
Dr. Reddy’s Secures Licensing Deal with Gilead for Lenacapavir in 120 Countries
The drug is currently approved for treating heavily treatment-experienced (HTE) adults with multi-drug resistant HIV.
HIV prevention: why a new injectable drug could be such a breakthrough – podcast
HIV expert Linda-Gail Bekker talks to The Conversation Weekly about promising results from a trial of a new drug for HIV ...
Gilead inks pact with six generic drugmakers on long-acting HIV injectable, even as civil society oppose patent application
Six drugmakers sign agreements with Gilead Sciences to produce generic lenacapavir, a long-acting HIV drug, amid patent ...
Emcure Pharmaceuticals partners with Gilead Sciences to produce HIV prevention drug Lenacapavir
Emcure Pharmaceuticals has partnered with Gilead Sciences Ireland UC to manufacture and distribute generic lenacapavir for ...